{"product_id":"oakstone-intensive-review-of-nephrology-2025","title":"Oakstone Intensive Review of Nephrology 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: clinical and academic nephrologists, internists, pediatricians, and primary care physicians\/trainees\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNew Release! Unmatched Board Prep and Nephrology Update\u003c\/p\u003e\n\u003cp\u003eGenetic testing for improved diagnosis, prognosis and therapy selection\u003c\/p\u003e\n\u003cp\u003eIntroduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation\u003c\/p\u003e\n\u003cp\u003ePhysical exam of the dialysis access\u003c\/p\u003e\n\u003cp\u003eFurther expansion of the roles of SGLT2i and finerenone in diabetic and non-diabetic kidney disease\u003c\/p\u003e\n\u003cp\u003eNew insights in immunology and the pathogenesis of glomerulonephritis\u003c\/p\u003e\n\u003cp\u003eNovel immunosuppressive agents for glomerulonephritis\u003c\/p\u003e\n\u003cp\u003eAnd more…\u003c\/p\u003e\n\u003cp\u003eDate of Original Release: October 15, 2025\u003c\/p\u003e\n\u003cp\u003eEstimated Time to Complete the Activity: 50.00 hours\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eSummarize current\/recommended nephrology guidelines in clinical practice\u003c\/p\u003e\n\u003cp\u003eExplain the differential diagnosis of complex clinical presentations of patients with renal disorders\u003c\/p\u003e\n\u003cp\u003eIdentify\/integrate current therapeutic options for specific renal disorders\u003c\/p\u003e\n\u003cp\u003eDescribe pathophysiological mechanisms as they apply to management of renal disease\u003c\/p\u003e\n\u003cp\u003eSynthesize teachings to better performance on the ABIM Nephrology certification\/recertification examinations\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRenal Physiology for the Boards – Melanie P. Hoenig, MD\u003c\/p\u003e\n\u003cp\u003eBasic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eUrine Sediment Analysis – Martina M. McGrath, MB BCh\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003ePathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD\u003c\/p\u003e\n\u003cp\u003eMetabolic Management of Kidney Stones – Gary Curhan, MD, ScD\u003c\/p\u003e\n\u003cp\u003eKeynote – AI in Nephrology – Girish N. Nadkarni, MD, MPH, CPH\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eTreating Lupus Nephritis in 2025 – New Guidelines, New Medications, and New Challenges – Gerald B. Appel, MD\u003c\/p\u003e\n\u003cp\u003eMembranous Nephropathy – Laurence H. Beck, Jr., MD, PhD\u003c\/p\u003e\n\u003cp\u003eAnemia Management – Update and Best Practices – Brona M. Moloney, MBBCH, BAO, MMSc\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eAcid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir\u003c\/p\u003e\n\u003cp\u003eAcid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, Bchir\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eSodium Disorders – David B. Mount, MD\u003c\/p\u003e\n\u003cp\u003ePotassium Disorders – David B. Mount, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eImportant New Trials in GN – David B. Mount, MD\u003c\/p\u003e\n\u003cp\u003eGenetics and Kidney Disease – Friedhelm Hildebrandt, MD\u003c\/p\u003e\n\u003cp\u003eUpdate on Polycystic Kidney Disease – Fouad T. Chebib, MD, FASN\u003c\/p\u003e\n\u003cp\u003ePediatric Nephrology – Michael J.G. Somers, MD\u003c\/p\u003e\n\u003cp\u003eGenetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD\u003c\/p\u003e\n\u003cp\u003eDiagnosis and Treatment of ANCA-associated Vasculitis – John L. Niles, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eWhy Do We Reject a Transplant? – Jamil R. Azzi, MD\u003c\/p\u003e\n\u003cp\u003eTransplant Immunosuppression for the Boards – Brittany L. Schreiber, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eImmunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD\u003c\/p\u003e\n\u003cp\u003eEarly Post-Transplant Management – Anil K. Chandraker, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eEvaluation of the Living Donor Candidate – Kassem Safa, MD\u003c\/p\u003e\n\u003cp\u003eLate Loss of the Kidney Transplant – Rania Khedher El Fekih, MD\u003c\/p\u003e\n\u003cp\u003eInfections in Transplant Recipients – Barbra M. Blair, MD\u003c\/p\u003e\n\u003cp\u003eMonitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD\u003c\/p\u003e\n\u003cp\u003ePre-Transplant Surgical Evaluation of Recipients – Rania Khedher El Fekih, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003ePoisonings and Intoxications – What a Nephrologist Needs to Know – Charlotte E. Goldfine, MD\u003c\/p\u003e\n\u003cp\u003eLate Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD\u003c\/p\u003e\n\u003cp\u003eHemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD\u003c\/p\u003e\n\u003cp\u003eGeriatric Nephrology – Ernest I. Mandel, MD\u003c\/p\u003e\n\u003cp\u003eCardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI\u003c\/p\u003e\n\u003cp\u003eManagement of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003ePrimary Aldosteronism – Anand Vaidya, MD, MMSc\u003c\/p\u003e\n\u003cp\u003eKeynote – Climate Change, Global Inequities, and the Kidney – Valerie A. Luyckx, MBBCh, MSc, PhD\u003c\/p\u003e\n\u003cp\u003eLiver and the Kidney – Andrew S. Allegretti, MD, MSc\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003ePathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD\u003c\/p\u003e\n\u003cp\u003eAcute Kidney Injury Syndromes – Alice Sheridan, MD\u003c\/p\u003e\n\u003cp\u003eICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eAcute Kidney Injury in Cancer – Raad Chowdhury, MD\u003c\/p\u003e\n\u003cp\u003eParaprotein-Induced Kidney Injury – Raad Chowdhury, MD\u003c\/p\u003e\n\u003cp\u003eTherapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2025 – Richard J. Glassock, MD\u003c\/p\u003e\n\u003cp\u003ePathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh\u003c\/p\u003e\n\u003cp\u003eAPOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003ePatient Perspective – Dialysis Dosing – Moderators – J. Kevin Tucker, MD and Paul Moore; Dialysis Patients – Daphne Rhodes and Vanessa Evans\u003c\/p\u003e\n\u003cp\u003eChronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eChronic Kidney Disease – Mineral and Bone Disease Case-Based Pearls – David Bushinsky, MD\u003c\/p\u003e\n\u003cp\u003eChronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eIntroduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC\u003c\/p\u003e\n\u003cp\u003eComplications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC\u003c\/p\u003e\n\u003cp\u003eAcute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eMesoamerican Nephropathy – David J. Friedman, MD\u003c\/p\u003e\n\u003cp\u003eUltrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD\u003c\/p\u003e\n\u003cp\u003eDialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD\u003c\/p\u003e\n\u003cp\u003eQuestion and Answer Session – Faculty\u003c\/p\u003e\n\u003cp\u003eGlomerulonephritis – Questions \u0026amp; Answers Session – Gerald B. Appel, MD\u003c\/p\u003e\n\u003cp\u003eMust-Know Clinical Images in Nephrology – Annie Liu, DO, MPH, MS\u003c\/p\u003e\n\u003cp\u003eElectrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, Bchir\u003c\/p\u003e\n\u003cp\u003eElectrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, Bchir\u003c\/p\u003e\n\u003cp\u003eChronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP\u003c\/p\u003e\n\u003cp\u003eCOVID-19 Vaccination in Immunocompromised Patients – Ann Woolley, MD\u003c\/p\u003e\n\u003cp\u003eUpdate on Renovascular Disease – Joseph M. Garasic, MD\u003c\/p\u003e\n\u003cp\u003ePre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD\u003c\/p\u003e\n\u003cp\u003eImmunologic Basis of Kidney Disease – Vivek Kasinath, MD\u003c\/p\u003e\n\u003cp\u003eUse of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD\u003c\/p\u003e\n\u003cp\u003eInterstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH\u003c\/p\u003e\n\u003cp\u003eEthics in Nephrology – Valerie Luyckx, MD, MB BCh\u003c\/p\u003e\n\u003cp\u003ePregnancy and Renal Disease – Jessica Tangren, MD\u003c\/p\u003e\n\u003cp\u003eMust-Know Board Zebras – Emily Robinson, MD, MPH\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405785714884,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Oakstone-Intensive-Review-of-Nephrology-2025.jpg?v=1784216132","url":"https:\/\/medicalcoursespro.com\/products\/oakstone-intensive-review-of-nephrology-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}